Agarwal Shefali

Director at FATE; Officer at Epizyme, Inc.

Sold, on record
$293k
Dollars the filings state
Form 4 sales
13
Latest Jun 7, 2022
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Epizyme, Inc.Plan not stated
    Jan 25 2021

    Sold 2,872 shares at $11.41 ($33k)

    Agarwal Shefali, Chief Medical Officer

    Sold 3.7% of holdings ($897k position)75,727 shares left1.6x usual sizeFiling

  2. 2 Form 4 sale Epizyme, Inc.Plan not stated
    Feb 4 +10 days

    Sold 969 shares at $11.21 ($11k)

    Agarwal Shefali, Chief Medical Officer

    Sold 0.9% of holdings ($1.2M position)104,341 shares left0.4x usual sizeFiling

  3. 3 Form 4 sale Epizyme, Inc.Plan not stated
    Dec 6 +305 days

    Sold 1,780 shares at $2.93 ($5k)

    Agarwal Shefali, Officer

    Sold 1.1% of holdings ($483k position)163,004 shares left0.8x usual sizeFiling

  4. 4 Form 4 sale Epizyme, Inc.Plan not stated
    Jan 26 +51 days

    Sold 2,922 shares at $2.02 ($6k)

    Agarwal Shefali, Officer

    Sold 1.8% of holdings ($329k position)160,082 shares left1.6x usual sizeFiling

  5. 5 Form 4 sale Epizyme, Inc.Plan not stated
    Feb 2 +7 days

    Sold 2,639 shares at $1.37 ($4k)

    Agarwal Shefali, Officer

    Sold 1.6% of holdings ($219k position)157,443 shares left1.5x usual sizeFiling

  6. 6 Form 4 sale Epizyme, Inc.Plan not stated
    Feb 7 +5 days

    Sold 1,058 shares at $1.50 ($2k)

    Agarwal Shefali, Officer

    Sold 0.7% of holdings ($236k position)156,385 shares left0.5x usual sizeFiling

  7. 7 Form 4 sale FATEUnusual
    Jun 3 +116 days

    Sold 807 shares at $22.80 ($18k)

    Agarwal Shefali, Director

    Sold 30.1% of holdings ($61k position)1,874 shares leftFirst sale on recordFiling

  8. 8 Form 4 sale FATEUnusual
    Jun 7 +4 days

    Sold 841 shares at $21.89 ($18k)

    Agarwal Shefali, Director

    Sold 31.4% of holdings ($59k position)1,840 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Agarwal Shefali
Source
Jun 7, 2022FATEDirectorForm 4 sale841$18k31.4%UnusualSEC
Jun 3, 2022FATEDirectorForm 4 sale807$18k30.1%UnusualSEC
Feb 7, 2022Epizyme, Inc.OfficerForm 4 sale1,058$2k0.7%Plan not statedSEC
Feb 2, 2022Epizyme, Inc.OfficerForm 4 sale2,639$4k1.6%Plan not statedSEC
Jan 26, 2022Epizyme, Inc.OfficerForm 4 sale2,922$6k1.8%Plan not statedSEC
Dec 6, 2021Epizyme, Inc.OfficerForm 4 sale1,780$5k1.1%Plan not statedSEC
Feb 4, 2021Epizyme, Inc.Chief Medical OfficerForm 4 sale969$11k0.9%Plan not statedSEC
Jan 25, 2021Epizyme, Inc.Chief Medical OfficerForm 4 sale2,872$33k3.7%Plan not statedSEC
Dec 3, 2020Epizyme, Inc.Chief Medical OfficerForm 4 sale2,522$34k3.2%Plan not statedSEC
Jun 26, 2020Epizyme, Inc.Chief Medical OfficerForm 4 sale1,805$29k2.2%Plan not statedSEC
Mar 25, 2020Epizyme, Inc.Chief Medical OfficerForm 4 sale1,243$19k1.7%Plan not statedSEC
Jan 27, 2020Epizyme, Inc.Chief Medical OfficerForm 4 sale4,473$99k7.1%Plan not statedSEC
Jun 14, 2019Epizyme, Inc.Chief Medical OfficerForm 4 sale1,195$14k3.2%Plan not statedSEC